LAG3 and amelogenesis imperfecta type 1G: Additionally, the immunoinhibitor LAG3 was significantly highly expressed in the ERS high-risk subgroup (p < 0.001), but CD160, CD274, KDR, PDCD1LG2, and TGFBR1 were expressed significantly less (Fig. 9D).